B7-1 (Protein | Antibody | cDNA Clone | ELISA Kit)

All B7-1 reagents are produced in house and quality controlled, including 21 B7-1 Antibody, 52 B7-1 Gene, 9 B7-1 Lysate, 10 B7-1 Protein, 3 B7-1 qPCR. All B7-1 reagents are ready to use.

B7-1 Background

The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD8, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD8 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

B7-1 References

  • Greenfield EA, et al. (1998) CD28/B7 costimulation: a review. Crit Rev Immunol. 18(5): 389-418.
  • Zang X, et al. (2007) The B7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res. 13(18 Pt 1): 5271-9.
  • Mir MA, et al. (2008) Signaling through CD80: an approach for treating lymphomas. Expert Opin Ther Targets. 12(8): 969-79.
彩票大奖得主捐赠 河内5分技巧 广西快3开奖记录查询 今日股票是涨是跌 福建即乐彩走势图 北京11选5开奖结果图 股票涨跌谁控制 福彩3d胆码拖图片 体彩快中彩20选8加4十1开奖结果 中国体育彩票网 体育彩票11选5开奖北京